Article info
Case report
Severe immune-mediated hepatitis caused by sindilizumab combined with local radiotherapy: a case report
- Correspondence to Jing Fang, Department of Oncology, Zhejiang Xiaoshan Hospital, Hangzhou, Zhejiang, 311202, China; fj15268118263{at}outkook.com
Citation
Severe immune-mediated hepatitis caused by sindilizumab combined with local radiotherapy: a case report
Publication history
- Received May 23, 2023
- Accepted July 11, 2023
- First published August 8, 2023.
Online issue publication
June 21, 2024
Article Versions
- Previous version (8 August 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.